30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Alder Biopharmaceuticals Inc (ALDR)

Track

Stock chart
Ticker: ALDR Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
H LUNDBECK A S
1 purchase — total 0 USD
Buy 22 Oct 2019
Value US$893,752.21 | Price 183.45 | Shares 98,082
Planned sale 16 Sep 2019
Value US$2,476,178.62 | Price 98.42 | Shares 2,591
Planned sale 25 Apr 2019
Value US$23,662.16 | Price 13.65 | Shares 1,734
Planned sale 25 Apr 2019
Value US$19,599.34 | Price 13.67 | Shares 1,434
Planned sale 25 Apr 2019
Value US$24,066.96 | Price 13.85 | Shares 1,738
Planned sale 25 Apr 2019
Value US$26,280.85 | Price 13.85 | Shares 1,897
Planned sale 3 Dec 2018
Value US$69,826.11 | Price 13.84 | Shares 5,044
Planned sale 1 Nov 2018
Value US$18,170.28 | Price 13.78 | Shares 1,319
Planned sale 1 Nov 2018
Value US$317,418.51 | Price 13.40 | Shares 23,683
Planned sale 1 Nov 2018
Value US$67,636.80 | Price 13.42 | Shares 5,040
Planned sale 1 Oct 2018
Value US$31,944.20 | Price 15.97 | Shares 2,000
Planned sale 1 Oct 2018
Value US$46,385.23 | Price 15.26 | Shares 3,040
Planned sale 1 Oct 2018
Value US$104,691.63 | Price 15.97 | Shares 6,554
Planned sale 1 Oct 2018
Value US$281,313.92 | Price 15.25 | Shares 18,445
Planned sale 4 Sep 2018
Value US$449,679.51 | Price 17.99 | Shares 24,999
Planned sale 4 Sep 2018
Value US$90,698.83 | Price 18.00 | Shares 5,040
Planned sale 1 Aug 2018
Value US$19,368.52 | Price 19.76 | Shares 980
Planned sale 1 Aug 2018
Value US$79,120.47 | Price 19.49 | Shares 4,060
Planned sale 1 Aug 2018
Value US$488,767.95 | Price 19.55 | Shares 24,999
Planned sale 2 Jul 2018
Value US$188,364.16 | Price 15.49 | Shares 12,161
Planned sale 2 Jul 2018
Value US$387,002.02 | Price 15.48 | Shares 24,999
Planned sale 1 Jun 2018
Value US$81,586.97 | Price 18.24 | Shares 4,474
Planned sale 1 Jun 2018
Value US$323,824.65 | Price 17.74 | Shares 18,253
Planned sale 1 Jun 2018
Value US$20,115.04 | Price 18.29 | Shares 1,100
Planned sale 1 Jun 2018
Value US$197,011.90 | Price 17.81 | Shares 11,061
Planned sale 1 Jun 2018
Value US$87,561.59 | Price 18.25 | Shares 4,799
Planned sale 1 Jun 2018
Value US$358,794.42 | Price 17.76 | Shares 20,200
Planned sale 16 May 2018
Value US$182,757.94 | Price 15.03 | Shares 12,161
Planned sale 13 Nov 2017
Value US$178,486.14 | Price 10.80 | Shares 16,519
Planned sale 16 Oct 2017
Value US$203,703.16 | Price 12.33 | Shares 16,520
Buy 18 Jul 2017
Value US$50,000.00 | Price 10.00 | Shares 5,000
Buy 18 Jul 2017
Value US$250,000.00 | Price 10.00 | Shares 25,000
Planned sale 20 Jun 2017
Value US$11,700.00 | Price 20.00 | Shares 585
Planned sale 9 Feb 2017
Value US$750,756.00 | Price 25.03 | Shares 30,000
Planned sale 18 Jan 2017
Value US$34,598.71 | Price 23.10 | Shares 1,498
Planned sale 9 Jan 2017
Value US$11,500.00 | Price 23.00 | Shares 500
Planned sale 6 Jan 2017
Value US$156,519.68 | Price 23.02 | Shares 6,800
Planned sale 5 Jan 2017
Value US$50,972.21 | Price 23.00 | Shares 2,216
Planned sale 1 Dec 2016
Value US$11,810.00 | Price 23.62 | Shares 500
Planned sale 1 Dec 2016
Value US$71,001.86 | Price 22.64 | Shares 3,136
Planned sale 1 Dec 2016
Value US$11,810.00 | Price 23.62 | Shares 500
Planned sale 1 Dec 2016
Value US$56,518.00 | Price 22.61 | Shares 2,500
Planned sale 9 Nov 2016
Value US$301,839.00 | Price 30.18 | Shares 10,000
Planned sale 7 Nov 2016
Value US$251,605.00 | Price 25.16 | Shares 10,000
Planned sale 1 Nov 2016
Value US$9,950.00 | Price 24.88 | Shares 400
Planned sale 1 Nov 2016
Value US$63,081.98 | Price 24.26 | Shares 2,600
Planned sale 17 Oct 2016
Value US$55,000.00 | Price 27.50 | Shares 2,000
Planned sale 17 Oct 2016
Value US$55,005.00 | Price 27.50 | Shares 2,000
Planned sale 17 Oct 2016
Value US$54,992.80 | Price 27.50 | Shares 2,000
Planned sale 3 Oct 2016
Value US$196,888.49 | Price 31.51 | Shares 6,249
Planned sale 3 Oct 2016
Value US$116,263.37 | Price 31.00 | Shares 3,751
Planned sale 3 Oct 2016
Value US$22,198.50 | Price 31.62 | Shares 702
Planned sale 3 Oct 2016
Value US$71,216.40 | Price 30.99 | Shares 2,298
Planned sale 3 Oct 2016
Value US$85,189.05 | Price 31.55 | Shares 2,700
Planned sale 3 Oct 2016
Value US$169,621.60 | Price 30.95 | Shares 5,481
Planned sale 1 Sep 2016
Value US$324,949.00 | Price 32.49 | Shares 10,000
Planned sale 1 Sep 2016
Value US$324,820.00 | Price 32.48 | Shares 10,000
Planned sale 1 Sep 2016
Value US$3,310.00 | Price 33.10 | Shares 100
Planned sale 1 Sep 2016
Value US$94,173.15 | Price 32.47 | Shares 2,900
Sale 15 Aug 2016
Value US$93,512.40 | Price 31.17 | Shares 3,000
Planned sale 1 Aug 2016
Value US$1,041.28 | Price 32.54 | Shares 32
Planned sale 1 Aug 2016
Value US$197,423.06 | Price 30.88 | Shares 6,394
Planned sale 1 Aug 2016
Value US$523.04 | Price 32.69 | Shares 16
Planned sale 1 Aug 2016
Value US$152,569.92 | Price 31.68 | Shares 4,816
Planned sale 1 Aug 2016
Value US$158,420.39 | Price 30.65 | Shares 5,168
Planned sale 27 Jul 2016
Value US$277,022.96 | Price 30.15 | Shares 9,187
Planned sale 26 Jul 2016
Value US$24,392.11 | Price 30.00 | Shares 813
Planned sale 25 Jul 2016
Value US$280,805.00 | Price 28.08 | Shares 10,000
Planned sale 13 Jun 2016
Value US$5,928.00 | Price 29.64 | Shares 200
Planned sale 13 Jun 2016
Value US$52,012.44 | Price 28.90 | Shares 1,800
Planned sale 13 Jun 2016
Value US$2,960.00 | Price 29.60 | Shares 100
Planned sale 13 Jun 2016
Value US$54,900.12 | Price 28.89 | Shares 1,900
Planned sale 13 Jun 2016
Value US$2,960.00 | Price 29.60 | Shares 100
Planned sale 13 Jun 2016
Value US$54,902.97 | Price 28.90 | Shares 1,900
Sale 3 Jun 2016
Value US$31,827.00 | Price 31.83 | Shares 1,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-10-24 2019-10-22 B Purchase
H LUNDBECK A S
Large shareholder
98,082
183.45
US$893,752 		98,082 183.45 US$893,752
2019-09-18 2019-09-16 PlS Planned sale
2.5
Smith Jeffrey T L

Managing Director
2,591 -10.2%
98.42
US$2,476,179 		2,591 -10.2% 98.42 US$2,476,179
2019-04-25 2019-04-25 PlS Planned sale
Benedict Larry

EVP and PAO
65,445 -40.1%
25.03
US$4,476,064 		65,445 -40.1% 25.03 US$4,476,064
2019-04-25 2019-04-25 PlS Planned sale
Lavelle Erin

Chief Operating Officer
1,434 -24.5%
13.67
US$19,599 		1,434 -24.5% 13.67 US$19,599
2019-04-25 2019-04-25 PlS Planned sale
Hassler Randal

EVP, Pharmaceutical Ops.
1,738 -24.2%
13.85
US$24,067 		1,738 -24.2% 13.85 US$24,067
2019-04-25 2019-04-25 PlS Planned sale
Bucher James B

EVP & General Counsel
1,897 -16.2%
13.85
US$26,281 		1,897 -16.2% 13.85 US$26,281
2018-12-04 2018-12-03 PlS Planned sale Smith Jeffrey T L

Managing Director

Officer
5,044 -85.9%
13.84
US$69,826 		5,044 -85.9% 13.84 US$69,826
2018-11-05 2018-11-01 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
1,319 -0.5%
13.78
US$18,170 		1,319 -0.5% 13.78 US$18,170
2018-11-05 2018-11-01 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
23,683 -8.8%
13.40
US$317,419 		23,683 -8.8% 13.40 US$317,419
2018-11-05 2018-11-01 PlS Planned sale Smith Jeffrey T L

Managing Director

Officer
5,040 -85.8%
13.42
US$67,637 		5,040 -85.8% 13.42 US$67,637
2018-10-03 2018-10-01 PlS Planned sale Smith Jeffrey T L

Managing Director

Officer
2,000 -70.6%
15.97
US$31,944 		2,000 -70.6% 15.97 US$31,944
2018-10-03 2018-10-01 PlS Planned sale Smith Jeffrey T L

Managing Director

Officer
3,040 -51.8%
15.26
US$46,385 		3,040 -51.8% 15.26 US$46,385
2018-10-03 2018-10-01 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
6,554 -2.6%
15.97
US$104,692 		6,554 -2.6% 15.97 US$104,692
2018-10-03 2018-10-01 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
18,445 -6.9%
15.25
US$281,314 		18,445 -6.9% 15.25 US$281,314
2018-09-06 2018-09-04 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
24,999 -9.3%
17.99
US$449,680 		24,999 -9.3% 17.99 US$449,680
2018-09-06 2018-09-04 PlS Planned sale Smith Jeffrey T L

Managing Director

Officer
5,040 -85.8%
18.00
US$90,699 		5,040 -85.8% 18.00 US$90,699
2018-08-02 2018-08-01 PlS Planned sale Smith Jeffrey T L

Managing Director

Officer
980 -54.1%
19.76
US$19,369 		980 -54.1% 19.76 US$19,369
2018-08-02 2018-08-01 PlS Planned sale Smith Jeffrey T L

Managing Director

Officer
4,060 -69.2%
19.49
US$79,120 		4,060 -69.2% 19.49 US$79,120
2018-08-02 2018-08-01 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
24,999 -9.3%
19.55
US$488,768 		24,999 -9.3% 19.55 US$488,768
2018-07-03 2018-07-02 PlS Planned sale Smith Jeffrey T L

Managing Director

Officer
12,161 -93.6%
15.49
US$188,364 		12,161 -93.6% 15.49 US$188,364
2018-07-03 2018-07-02 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
24,999 -9.3%
15.48
US$387,002 		24,999 -9.3% 15.48 US$387,002
2018-06-05 2018-06-01 PlS Planned sale Litton Mark James

Chief Business Officer

Officer
4,474 -4.2%
18.24
US$81,587 		4,474 -4.2% 18.24 US$81,587
2018-06-05 2018-06-01 PlS Planned sale Litton Mark James

Chief Business Officer

Officer
18,253 -14.6%
17.74
US$323,825 		18,253 -14.6% 17.74 US$323,825
2018-06-05 2018-06-01 PlS Planned sale Smith Jeffrey T L

Managing Director

Officer
1,100 -57.0%
18.29
US$20,115 		1,100 -57.0% 18.29 US$20,115
2018-06-05 2018-06-01 PlS Planned sale Smith Jeffrey T L

Managing Director

Officer
11,061 -85.1%
17.81
US$197,012 		11,061 -85.1% 17.81 US$197,012
2018-06-05 2018-06-01 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
4,799 -1.9%
18.25
US$87,562 		4,799 -1.9% 18.25 US$87,562
2018-06-05 2018-06-01 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
20,200 -7.5%
17.76
US$358,794 		20,200 -7.5% 17.76 US$358,794
2018-05-18 2018-05-16 PlS Planned sale Smith Jeffrey T L

Managing Director

Officer
12,161 -93.6%
15.03
US$182,758 		12,161 -93.6% 15.03 US$182,758
2017-11-15 2017-11-13 PlS Planned sale Litton Mark James

Chief Business Officer
16,519 -14.2%
10.80
US$178,486 		16,519 -14.2% 10.80 US$178,486
2017-10-18 2017-10-16 PlS Planned sale Litton Mark James

Chief Business Officer
16,520 -14.2%
12.33
US$203,703 		16,520 -14.2% 12.33 US$203,703
2017-07-18 2017-07-18 B Purchase YARNO WENDY L Non-Executive Director
5,000 +inf%
10.00
US$50,000 		5,000 +inf% 10.00 US$50,000
2017-07-18 2017-07-18 B Purchase DOW STEPHEN M Non-Executive Director
25,000 +8.9%
10.00
US$250,000 		25,000 +8.9% 10.00 US$250,000
2017-06-22 2017-06-20 PlS Planned sale Smith Jeffrey T L

Sr. VP Translational Medicine
585 -41.3%
20.00
US$11,700 		585 -41.3% 20.00 US$11,700
2017-02-13 2017-02-09 PlS Planned sale Schatzman Randall C

President and CEO

Executive Director
30,000 -20.7%
25.03
US$750,756 		30,000 -20.7% 25.03 US$750,756
2017-01-20 2017-01-18 PlS Planned sale Litton Mark James

Chief Business Officer
1,498 -1.5%
23.10
US$34,599 		1,498 -1.5% 23.10 US$34,599
2017-01-09 2017-01-09 PlS Planned sale Litton Mark James

Chief Business Officer
500 -0.5%
23.00
US$11,500 		500 -0.5% 23.00 US$11,500
2017-01-09 2017-01-06 PlS Planned sale Litton Mark James

Chief Business Officer
6,800 -6.4%
23.02
US$156,520 		6,800 -6.4% 23.02 US$156,520
2017-01-09 2017-01-05 PlS Planned sale Litton Mark James

Chief Business Officer
2,216 -2.2%
23.00
US$50,972 		2,216 -2.2% 23.00 US$50,972
2016-12-05 2016-12-01 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
500 -0.2%
23.62
US$11,810 		500 -0.2% 23.62 US$11,810
2016-12-05 2016-12-01 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
3,136 -1.3%
22.64
US$71,002 		3,136 -1.3% 22.64 US$71,002
2016-12-05 2016-12-01 PlS Planned sale Smith Jeffrey T L

Sr. VP Translational Medicine

Officer
500 -37.6%
23.62
US$11,810 		500 -37.6% 23.62 US$11,810
2016-12-05 2016-12-01 PlS Planned sale Smith Jeffrey T L

Sr. VP Translational Medicine

Officer
2,500 -65.3%
22.61
US$56,518 		2,500 -65.3% 22.61 US$56,518
2016-11-14 2016-11-09 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
10,000 -4.0%
30.18
US$301,839 		10,000 -4.0% 30.18 US$301,839
2016-11-09 2016-11-07 PlS Planned sale Schatzman Randall C

President and CEO

Executive Director
10,000 -8.0%
25.16
US$251,605 		10,000 -8.0% 25.16 US$251,605
2016-11-03 2016-11-01 PlS Planned sale Smith Jeffrey T L

Sr. VP Translational Medicine

Officer
400 -100.0%
24.88
US$9,950 		400 -100.0% 24.88 US$9,950
2016-11-03 2016-11-01 PlS Planned sale Smith Jeffrey T L

Sr. VP Translational Medicine

Officer
2,600 -86.7%
24.26
US$63,082 		2,600 -86.7% 24.26 US$63,082
2016-10-19 2016-10-17 PlS Planned sale Litton Mark James

Chief Business Officer

Officer
2,000 -7.1%
27.50
US$55,000 		2,000 -7.1% 27.50 US$55,000
2016-10-19 2016-10-17 PlS Planned sale Litton Mark James

Chief Business Officer

Officer
2,000 -7.1%
27.50
US$55,005 		2,000 -7.1% 27.50 US$55,005
2016-10-19 2016-10-17 PlS Planned sale Litton Mark James

Chief Business Officer

Officer
2,000 -7.1%
27.50
US$54,993 		2,000 -7.1% 27.50 US$54,993
2016-10-05 2016-10-03 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
6,249 -2.5%
31.51
US$196,888 		6,249 -2.5% 31.51 US$196,888
2016-10-05 2016-10-03 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
3,751 -1.5%
31.00
US$116,263 		3,751 -1.5% 31.00 US$116,263
2016-10-05 2016-10-03 PlS Planned sale Smith Jeffrey T L

Sr. VP Translational Medicine

Officer
702 -100.0%
31.62
US$22,199 		702 -100.0% 31.62 US$22,199
2016-10-05 2016-10-03 PlS Planned sale Smith Jeffrey T L

Sr. VP Translational Medicine

Officer
2,298 -76.6%
30.99
US$71,216 		2,298 -76.6% 30.99 US$71,216
2016-10-05 2016-10-03 PlS Planned sale Schatzman Randall C

President and CEO

Executive Director
2,700 -2.3%
31.55
US$85,189 		2,700 -2.3% 31.55 US$85,189
2016-10-05 2016-10-03 PlS Planned sale Schatzman Randall C

President and CEO

Executive Director
5,481 -4.5%
30.95
US$169,622 		5,481 -4.5% 30.95 US$169,622
2016-09-06 2016-09-01 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
10,000 -4.0%
32.49
US$324,949 		10,000 -4.0% 32.49 US$324,949
2016-09-06 2016-09-01 PlS Planned sale Schatzman Randall C

President and CEO

Executive Director
10,000 -8.0%
32.48
US$324,820 		10,000 -8.0% 32.48 US$324,820
2016-09-06 2016-09-01 PlS Planned sale Smith Jeffrey T L

Sr. VP Translational Medicine

Officer
100 -100.0%
33.10
US$3,310 		100 -100.0% 33.10 US$3,310
2016-09-06 2016-09-01 PlS Planned sale Smith Jeffrey T L

Sr. VP Translational Medicine

Officer
2,900 -96.7%
32.47
US$94,173 		2,900 -96.7% 32.47 US$94,173
2016-08-17 2016-08-15 S Sale Smith Jeffrey T L

Sr. VP Translational Medicine

Officer
3,000 -100.0%
31.17
US$93,512 		3,000 -100.0% 31.17 US$93,512
2016-08-03 2016-08-01 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
32 -0.0%
32.54
US$1,041 		32 -0.0% 32.54 US$1,041
2016-08-03 2016-08-01 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
6,394 -2.5%
30.88
US$197,423 		6,394 -2.5% 30.88 US$197,423
2016-08-03 2016-08-01 PlS Planned sale Schatzman Randall C

President and CEO

Executive Director
16 -0.0%
32.69
US$523 		16 -0.0% 32.69 US$523
2016-08-03 2016-08-01 PlS Planned sale Schatzman Randall C

President and CEO

Executive Director
4,816 -4.0%
31.68
US$152,570 		4,816 -4.0% 31.68 US$152,570
2016-08-03 2016-08-01 PlS Planned sale Schatzman Randall C

President and CEO

Executive Director
5,168 -4.1%
30.65
US$158,420 		5,168 -4.1% 30.65 US$158,420
2016-07-28 2016-07-27 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
9,187 -3.7%
30.15
US$277,023 		9,187 -3.7% 30.15 US$277,023
2016-07-28 2016-07-26 PlS Planned sale Latham John A

Chief Scientific Officer

Officer
813 -0.3%
30.00
US$24,392 		813 -0.3% 30.00 US$24,392
2016-07-27 2016-07-25 PlS Planned sale Schatzman Randall C

President and CEO

Executive Director
10,000 -8.0%
28.08
US$280,805 		10,000 -8.0% 28.08 US$280,805
2016-06-15 2016-06-13 PlS Planned sale Litton Mark James

Chief Business Officer

Officer
200 -0.7%
29.64
US$5,928 		200 -0.7% 29.64 US$5,928
2016-06-15 2016-06-13 PlS Planned sale Litton Mark James

Chief Business Officer

Officer
1,800 -6.0%
28.90
US$52,012 		1,800 -6.0% 28.90 US$52,012
2016-06-15 2016-06-13 PlS Planned sale Litton Mark James

Chief Business Officer

Officer
100 -0.4%
29.60
US$2,960 		100 -0.4% 29.60 US$2,960
2016-06-15 2016-06-13 PlS Planned sale Litton Mark James

Chief Business Officer

Officer
1,900 -6.3%
28.89
US$54,900 		1,900 -6.3% 28.89 US$54,900
2016-06-15 2016-06-13 PlS Planned sale Litton Mark James

Chief Business Officer

Officer
100 -0.4%
29.60
US$2,960 		100 -0.4% 29.60 US$2,960
2016-06-15 2016-06-13 PlS Planned sale Litton Mark James

Chief Business Officer

Officer
1,900 -6.3%
28.90
US$54,903 		1,900 -6.3% 28.90 US$54,903
2016-06-07 2016-06-03 S Sale Smith Jeffrey T L

Sr. VP Translational Medicine

Officer
1,000 -100.0%
31.83
US$31,827 		1,000 -100.0% 31.83 US$31,827
Explore more

More insider trading research around Alder Biopharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America